Abstract:The control of retroviral infection by antiviral factors referred to as restriction factors has become an exciting area in infectious disease research. TRIM5α has emerged as an important restriction factor impacting on retroviral replication including HIV-1 replication in primates. TRIM5α has a tripartite motif comprising RING, B-Box and coiled coil domains. The antiviral α splice variant additionally encodes a B30.2 domain which is recruited to incoming viral cores and determines antiviral specificity. TRIM5 is ubiquitinylated and rapidly turned over by the proteasome in a RING dependent way. Protecting restricted virus from degradation, by inhibiting the proteasome, rescues DNA synthesis, but not infectivity, indicating that restriction of infectivity by TRIM5α does not depend on the proteasome but the early block to DNA synthesis is likely to be mediated by rapid degradation of the restricted cores. The peptidyl prolyl isomerase enzyme cyclophilin A isomerises a peptide bond on the surface of the HIV-1 capsid and impacts on sensitivity to restriction by TRIM5α from Old World monkeys. This suggests that TRIM5α from Old World monkeys might have a preference for a particular capsid isomer and suggests a role for cyclophilin A in innate immunity in general. Whether there are more human antiviral TRIMs remains uncertain although the evidence for TRIM19's (PML) antiviral properties continues to grow. A TRIM5-like molecule with broad antiviral activity in cattle suggests that TRIM mediated innate immunity might be common in mammals. Certainly the continued study of restriction of viral infectivity by antiviral host factors will remain of interest to a broad audience and impact on a variety of areas including development of animal models for infection, development of viral vectors for gene therapy and the search for novel antiviral drug targets.

Tripartite-motif proteins and innate immune regulation

Tripartite motif proteins: an emerging antiviral protein family

InTRIMsic immunity: Positive and negative regulation of immune signaling by tripartite motif proteins

To TRIM the Immunity: From Innate to Adaptive Immunity

Regulation of Tripartite Motif-Containing Proteins on Immune Response and Viral Evasion

Regulation of innate immune signalling pathways by the tripartite motif (TRIM) family proteins

TRIM Proteins in Inflammation: from Expression to Emerging Regulatory Mechanisms

The control of viral infection by tripartite motif proteins and cyclophilin A

The interplay between viruses and TRIM family proteins

To TRIM or not to TRIM: the balance of host-virus interactions mediated by the ubiquitin system

Mechanistic Role of TRIM26 in Viral Infection and Host Defense

TRIM25 and its emerging RNA-binding roles in antiviral defense

Exploring TRIM proteins' role in antiviral defense against influenza A virus and respiratory coronaviruses

TRIM21 is Essential to Sustain IFN Regulatory Factor 3 Activation During Antiviral Response

Multifaceted Roles of TRIM38 in Innate Immune and Inflammatory Responses

TRIM 30 a negatively regulates TLR-mediated NF-j B activation by targeting TAB 2 and TAB 3 for degradation

Regulation of Mitochondria-Derived Immune Activation by 'Antiviral' TRIM Proteins

TRIM5α: A Protean Architect of Viral Recognition and Innate Immunity

TRIM65 regulates innate immune signaling by enhancing K6-linked ubiquitination of IRF3 and its chromatin recruitment

Multifaceted role of TRIM21 in inflammation

Multi-Directional Mechanisms of Participation of the TRIM Gene Family in Response of Innate Immune System to Bacterial Infections